非节段型白癜风治疗中的免疫与生物学变化及其与复色的关系
这项前瞻性探索性研究纳入30例非节段型白癜风患者(11例起始标准外用治疗,19例联合窄谱UVB光疗),评估治疗早期皮损与非皮损皮肤蛋白差异及细胞和蛋白标志物变化与临床复色的关系。研究发现治疗3个月后皮肤CD3+、CD8+ T及组织驻留记忆细胞减少,伴47种疱液蛋白变化;组织驻留记忆细胞、Tr1及分泌IL-10的Tr1细胞和脂肪酸结合蛋白4下降与复色相关。
要点
- 治疗前皮损与非皮损皮肤蛋白差异不反映早期治疗变化或复色关联。
- 治疗3个月后皮肤CD3+、CD8+ T及组织驻留记忆细胞减少。
- 组织驻留记忆细胞、Tr1及分泌IL-10的Tr1细胞和FABP4下降与复色相关。
核心结论
- 治疗前皮损与非皮损皮肤差异不反映早期治疗变化或复色关联。
- 皮肤组织驻留记忆细胞和血分泌IL-10的Tr1细胞及FABP4下降与复色相关。
研究设计与样本
- 前瞻性探索性研究,纳入30例非节段型白癜风患者,11例起始标准外用治疗,19例联合窄谱UVB光疗。
主要发现
- 治疗前疱液中有53种蛋白在皮损与非皮损皮肤间存在差异。
- 治疗3个月后皮肤活检中CD3+、CD8+ T及组织驻留记忆(CD69+CD103-)细胞减少,伴47种疱液蛋白变化。
- 血中循环滤泡辅助性T17、CD336+Nkbright、1型调节性T(Tr1)及分泌IL-10的Tr1细胞比例下降。
- 组织驻留记忆细胞、Tr1及分泌IL-10的Tr1细胞和脂肪酸结合蛋白4下降与基线及6个月时白癜风面积评分复色相关。
临床怎么用
- 治疗早期监测皮肤组织驻留记忆细胞和血分泌IL-10的Tr1细胞及FABP4变化可能有助于评估复色反应。
局限性
- 探索性研究样本量较小(30例),治疗分组非随机(11例外用 vs 19例联合光疗)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The treatment of nonsegmental vitiligo remains challenging and poorly understood. The aim of this study was to evaluate protein differences in lesional and nonlesional skin and changes of cellular and proteomic markers early in treatment in lesional skin and blood in relation to clinical response. This prospective exploratory study was conducted in 30 patients with nonsegmental vitiligo, 11 starting with standard-of-care topical therapy and 19 starting in combination with narrow-band UVB phototherapy. We identified 53 proteins that differed between blister fluids from lesional and nonlesional skin before treatment. After 3 months of therapy, CD3+, CD8+ T, and tissue-resident memory (CD69+CD103-) cell populations decreased in skin biopsies, together with changes in 47 blister fluid proteins. Percentages of circulating follicular T helper type 17, CD336+Nkbright, type 1 regulatory T (Tr1), and IL-10-secreting Tr1 cells decreased in blood. Decreases in tissue-resident memory, Tr1, and IL-10-secreting Tr1 cells and fatty acid-binding protein 4 were associated with repigmentation, measured by Vitiligo Extent Score at baseline and 6 months. Differences in lesional and nonlesional skin prior to treatment do not reflect changes in lesional skin early in therapy nor associations with clinical repigmentation response. We found an association between decreasing fatty acid-binding protein 4 and tissue-resident memory cells in the skin and IL-10-secreting Tr1 cells in the blood and repigmentation response to treatment of vitiligo.
引用
- Ouwerkerk W, Narayan VS, Chielie S, et al. Immune and Biological Changes during Treatment in Patients with Nonsegmental Vitiligo and their Relation to Repigmentation. J Invest Dermatol. 2025. PMID: 40848929. doi:10.1016/j.jid.2025.07.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。